PPET Edison Equity Proposition

Driving Healthcare Innovation: Private Equity’s Role in the Tech Revolution

In this article, Karin Hyland, Deputy Head of Co-investments and Andrew McMillan, Investment Manager explain the impact the global healthcare system faces and how investing in healthcare in the mid-market can ease some of these mounting pressures.

Read more

Video

A Year of Positive Change For PPET

Alan Gauld, Senior Investment Director for Patria Private Equity Trust gives an update on the move from abrdn to Patria and the benefits this has brought for the team and PPET.

Read more

Completion of a successful £180m secondary sale

Patria Private Equity Trust (PPET) has announced that it has completed a secondary sale of a portfolio of 14 older vintage and non-core investments for c €216m (c £180m or 13% of PPET’s end-August 2024 NAV). This represents a minor 5% discount to the carrying value of the sold assets at end-March 2024 (H124) and translates into a robust 1.9x multiple on invested capital and a 16% internal rate of return (IRR).

Read more

Latest Edison Research Note - 25 June 2024

Patria Private Equity Trust (PPET) reported a modest 2.0% NAV per share total return in H124 (ending March 2024) as exit activity in private equity markets remained subdued...

Read more